<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Almgrami RT</submitter><funding>Postdoctoral Fellowship Program</funding><funding>Medical Science and Technology Research Project of Henan Province</funding><funding>Key Special Project for International Science and Technology Innovation Cooperation between Governments under the National Key R&amp;amp;D Program</funding><funding>Postdoctoral Fellowship Program (Grade C)</funding><funding>National Natural Science Foundation of China-General Project</funding><funding>Key Special Project for International Science and Technology Innovation Cooperation between Governments under the National Key R&amp;D Program</funding><funding>National Natural Science Foundation of China–General Project</funding><funding>National Natural Science Foundation of China Joint Fund Key Support Project</funding><pagination>319</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12480184</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>74(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Metastatic lung carcinoma poses considerable treatment difficulties. It exhibits cellular characteristics that differ from those of early-stage cancer. Immunotherapy demonstrates enhanced hope for patients with advanced and metastatic lung cancer. Tumor-associated macrophages (TAMs) may be a contributing factor that diminishes the effectiveness of immunotherapy. Secreted phosphoprotein 1 (SPP1)&lt;sup>+ &lt;/sup>TAMs are considered to possess immunosuppressive characteristics, as their interaction with CD8&lt;sup>+&lt;/sup> T lymphocytes results in the exhaustion of these cells.&lt;h4>Methods&lt;/h4>We analyzed single-cell RNA sequencing datasets of lung cancer metastases in order to examine the development of brain metastatic tumors. Furthermore, the cell-cell interactions between SPP1&lt;s</pubmed_abstract><journal>Cancer immunology, immunotherapy : CII</journal><pubmed_title>Single-cell transcriptomic analyses provide insights into SPP1&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; TAM-mediated immune suppression and CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T cell dysfunction in lung cancer.</pubmed_title><pmcid>PMC12480184</pmcid><funding_grant_id>252102311163</funding_grant_id><funding_grant_id>2022YFE0141000</funding_grant_id><funding_grant_id>GZC20232435</funding_grant_id><funding_grant_id>U24A20734</funding_grant_id><funding_grant_id>82272873</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Almgrami RT</pubmed_authors><pubmed_authors>Zhao Q</pubmed_authors><pubmed_authors>You M</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell transcriptomic analyses provide insights into SPP1&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; TAM-mediated immune suppression and CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T cell dysfunction in lung cancer.</name><description>&lt;h4>Background&lt;/h4>Metastatic lung carcinoma poses considerable treatment difficulties. It exhibits cellular characteristics that differ from those of early-stage cancer. Immunotherapy demonstrates enhanced hope for patients with advanced and metastatic lung cancer. Tumor-associated macrophages (TAMs) may be a contributing factor that diminishes the effectiveness of immunotherapy. Secreted phosphoprotein 1 (SPP1)&lt;sup>+ &lt;/sup>TAMs are considered to possess immunosuppressive characteristics, as their interaction with CD8&lt;sup>+&lt;/sup> T lymphocytes results in the exhaustion of these cells.&lt;h4>Methods&lt;/h4>We analyzed single-cell RNA sequencing datasets of lung cancer metastases in order to examine the development of brain metastatic tumors. Furthermore, the cell-cell interactions between SPP1&lt;s</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-04T12:18:18.793Z</modification><creation>2026-05-09T03:08:01.156Z</creation></dates><accession>S-EPMC12480184</accession><cross_references><pubmed>41021043</pubmed><doi>10.1007/s00262-025-04180-3</doi></cross_references></HashMap>